KELLY ALLEN: Open Payments
NPI 1033549605 · WARREN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,055 in 110 payments from 13 companies in 2025. Trend: 2023 $1,043 · 2024 $1,170 · 2025 $2,055
Food & beverage: $2,055
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 36 | $461 |
| Alkermes, Inc. | 14 | $417 |
| Axsome Therapeutics, Inc. | 10 | $300 |
| Otsuka America Pharmaceutical, Inc. | 10 | $192 |
| Janssen Pharmaceuticals, Inc | 8 | $142 |
| Lundbeck LLC | 7 | $120 |
| E.R. Squibb & Sons, L.L.C. | 7 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
Products named: UZEDY, ARISTADA, Auvelity, REXULTI, INVEGA SUSTENNA, COBENFY, LYBALVI, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
